Scitus has an Impressive Regulatory track history of conducting BA/BE studies for global regulatory agencies.

SCITUS facilities are approved by the Drug Controller General of India.

Scitus facilities are inspected by the USFDA based on the bio-studies submitted to the agency.

Gulf Cooperation Council (GCC) has approved the bio study conducted by SCITUS.

Feb 2018 & Oct 2019

(Certificate Received)

Feb 2019 & Jan 2021

(EIR Received)

Submitted Study
Approved by GCC

(on Nov 2021)

Submitted Studies
to MHRA and

awaiting inspection